7 results
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... Epidemiology: • 1-2 cases ... Treatment: • Plasmapheresis ... Syndrome #diagnosis #management ... #treatment #neurology
Diabetic Ketoacidosis 
Management Priorities
1. Fluids 
2. Insulin 
3. Potassium 
4. Acidosis 
5. Re-establish oral fluids,
Management Priorities ... Identification and treatment ... an underlying cause ... #Management #Pediatrics ... #Peds
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... Incidence: 1 to 2 cases ... and cauda equina TREATMENT ... Syndrome #diagnosis #management ... #neurology
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
muscles: “myasthenic crises ... Myasthenia Crises ... immunosuppressants - Meds ... Gravis #diagnosis #management ... #neurology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
irrigation • Management ... • Nephrogenic diabetes ... Kidney stones caused ... Tolvaptan) • Treatment ... Excretion #Diuresis #Nephrology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
may precede the neurologic ... the underlying cause ... • Treatment of ... Syndrome #diagnosis #management ... #neurology
Hypermagnesemia - Diagnosis and Management

Hypermagnesemia is a serum magnesium concentration > 2.6 mg/dL.
Symptoms include hyporeflexia, hypotension,
Diagnosis and Management ... mortality in ICU Causes ... antacids, or enemas, Treatment ... and neonates), Diabetic ... #magnesium #nephrology